MA44503B1 - PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS - Google Patents
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORSInfo
- Publication number
- MA44503B1 MA44503B1 MA44503A MA44503A MA44503B1 MA 44503 B1 MA44503 B1 MA 44503B1 MA 44503 A MA44503 A MA 44503A MA 44503 A MA44503 A MA 44503A MA 44503 B1 MA44503 B1 MA 44503B1
- Authority
- MA
- Morocco
- Prior art keywords
- pyrrolotriazine compounds
- inhibitors
- tam inhibitors
- compounds
- tam
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000003921 pyrrolotriazines Chemical class 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette demande concerne des composés de formule i, ou des sels pharmaceutiquement acceptables de ceux-ci, qui sont des inhibiteurs de tam kinases utiles pour le traitement de troubles tels que le cancer.This application relates to compounds of formula i, or pharmaceutically acceptable salts thereof, which are inhibitors of tam kinases useful for the treatment of disorders such as cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662314066P | 2016-03-28 | 2016-03-28 | |
| PCT/US2017/024270 WO2017172596A1 (en) | 2016-03-28 | 2017-03-27 | Pyrrolotriazine compounds as tam inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA44503A MA44503A (en) | 2019-02-06 |
| MA44503B1 true MA44503B1 (en) | 2023-11-30 |
Family
ID=63036861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA44503A MA44503B1 (en) | 2016-03-28 | 2017-03-27 | PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR107984A1 (en) |
| MA (1) | MA44503B1 (en) |
-
2017
- 2017-03-27 AR ARP170100750A patent/AR107984A1/en unknown
- 2017-03-27 MA MA44503A patent/MA44503B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA44503A (en) | 2019-02-06 |
| AR107984A1 (en) | 2018-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43169B1 (en) | Heterocyclic compounds as pi3k-gamma inhibitors | |
| MA52486B1 (en) | Pyridazinones used as parp7 inhibitors | |
| MY202022A (en) | Pyrrolotriazine compounds as tam inhibitors | |
| MA47079A (en) | AMINO-TRIAZOLOPYIDINE COMPOUNDS AND THEIR USE TO TREAT CANCER | |
| MA40123A1 (en) | Pyrimidines used as factor xia inhibitors | |
| MA39898B1 (en) | 4-amino-imidazoquinoline compounds | |
| MA40111B1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
| MA45153B1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| EA201691401A1 (en) | INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS | |
| MA40225A (en) | SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS | |
| MA54386B1 (en) | TREX1 MODULATORS | |
| MA38483A1 (en) | Inhibitors of ido | |
| MA40955B1 (en) | 2-amino-6- (difluoromethyl) -5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors | |
| TN2015000347A1 (en) | AZABENZIMIDAZOLES AS INHIBITORS OF PDE4 ISOENZYMES FOR THE TREATMENT OF CNS DISORDERS AND OTHER DISORDERS | |
| MA54133B1 (en) | Aminopyrazine diol compounds used as pi3k-y inhibitors | |
| MA43409B1 (en) | Polycyclic compounds for use as bruton tyrosine kinase inhibitors | |
| MA46229B1 (en) | Heteroaryl carboxamide compounds as inhibitors of ripk2 | |
| MA50013B1 (en) | BENZOAZEPINE ANALOGS AS BRUTON'S TYROSINE KINASE INHIBITORS | |
| MA39171A1 (en) | Hydroxy formamide derivatives and their use | |
| MA50398B1 (en) | Condensed imidazole derivatives, substituted by tertiary hydroxy groups, used as inhibitors of pi3k-gamma | |
| EA201692260A1 (en) | 1,3,4-TIADIAZOLE COMPOUNDS AND THEIR APPLICATION IN CANCER TREATMENT | |
| MA37765A1 (en) | Substituted pyrazole compounds used as lpar antagonists | |
| MA43913B1 (en) | Positive allosteric modulators of the m1 muscarinic receptor | |
| MA39337A1 (en) | Modulators of pyrazines of gpr6 | |
| MA46965B1 (en) | Gamma ror (rory) modulators |